Similar Articles
951 Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation
952 Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma
953 Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
954 Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience
955 Proposal of new expanded selection criteria using total tumor size and 18F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria
956 MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737
957 Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients
958 Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma
959 Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments
960 Apoptosis induced by a low-carbohydrate and high-protein diet in rat livers
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA